Iovance Biotherapeutics, Inc. (IOVA) NASDAQ
3.57
+0.13(+3.78%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.57
+0.13(+3.78%)
Currency In USD
| Market Cap | 975.55M |
| Enterprise Value | 860.92M |
| P/E Ratio | -3.58 |
| PEG Ratio | -0.2 |
| Price/Sales Ratio | 4.33 |
| Price/Book Ratio | 2 |
| Enterprise/Revenue | 3.9 |
| Enterprise/EBITDA | -2.84 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -1.48 |
| Operating Margin | -1.53 |
| Return On Assets | -0.43 |
| Return On Equity | -0.55 |
| Revenue | 263.5M |
| Revenue/Share | 0.65 |
| Gross Profit | 256.22M |
| EBITDA | -357.11M |
| Net Income | -390.98M |
| Diluted EPS | -1.09 |
| Total Cash | 296.98M |
| Total Cash/Share | 0.73 |
| Total Debt | 48.44M |
| Total Debt/Equity | 0.07 |
| Current Ratio | 3.2 |
| Book Value Per Share | 1.72 |
| 52-Week Change | -4.71 |
| 52-Week High | 5.63 |
| 52-Week Low | 1.64 |
| Moving Average 50 Days | 3.7 |
| Moving Average 200 Days | 2.72 |
| Average Volume | 15.69M |
| Shares Outstanding | 331.69M |
| % Held by Institutions | 71.86 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
| Last Split Date | September 26, 2013 |